Natural Products
| Catalog No. | Information |
| CFN60449 | MK-0752 |
| CFN60450 | CP-724714 |
| CFN60451 | Odanacatib (MK-0822) |
| CFN60452 | Fludarabine Phosphate |
| CFN60453 | Linifanib (ABT-869) |
| CFN60454 | GSK1059615 |
| CFN95257 | Vanillic acid glucoside Reference standards. |
| CFN95258 | New compound 5 Reference standards. |
| CFN95259 | New compound 6 Reference standards. |
| CFN95260 | Phyllanthusiin C Reference standards. |
| CFN95261 | 15-Methoxy-16-oxo-15,16H-strictic acid Reference standards. |
| CFN95262 | 15-Deoxypulic acid Reference standards. |
| CFN91830 | Pongamol |
| CFN91828 | Colchiceine |
| CFN91827 | Neosalvianen |
| CFN95263 | Indolelactic acid Indolelactic acid is a phytochormone. |
| CFN95264 | N-trans-caffeoyloctopamine N-trans-Caffeoyltyramine has both arginase inhibitory property and antioxidant capacity. |
| CFN95265 | N-trans-caffeoyltyramine N-trans-caffeoyltyramine is a novel and potent modulator of inflammatory responses. |
| CFN95266 | Bidenoside C Bidenoside C may have hepatoprotective activity. |
| CFN95267 | Saucerneol Saucerneol has significant cardiovascular effects such as vasorelaxant and negative inotropic actions. |
| CFN95268 | Cannabisin B Cannabisin B possesses considerable antiproliferative activity and that it may be utilised as a promising chemopreventive agent against hepatoblastoma disease. It induces autophagic cell death by inhibiting the AKT/mTOR pathway and S phase cell cycle arrest in HepG2 cell. |
| CFN91826 | 4'-Methylchrysoeriol 4'-Methylchrysoeriol is a potent inhibitor of Cytochrome P450 enzymes, with an IC50 of 19 nM for human P450 1B1-dependent EROD. |
| CFN95269 | 2-Methoxy-1,4-naphthoquinone |
| CFN95270 | Aegineoside |
| CFN95271 | Quercetin-3'-glucoside |
| CFN95272 | Peucenidin |
| CFN95273 | Isoedultin |
| CFN95274 | 9-Hydroxy-O-senecioyl-8,9-dihydrooroselol |
| CFN95275 | Daucoidin A |
| CFN95276 | Apigenin 4'-O-(2'',6''-di-O-E-p-coumaroyl)glucoside |
| CFN91825 | Harmol |
| CFN91824 | Rosmaquinone |
| CFN95277 | Quercetin 3-O-beta-D-glucosyl-(1->2)-rhamnoside |
| CFN95278 | Cannabiscitrin |
| CFN91823 | Clausine E Clausine E as an inhibitor of fat mass and obesity‐associated protein (FTO) demethylase activity. The characteristics of the binding between Clausine E and the fat mass and obesity‐associated protein were investigated by physicochemical and spectroscopic techniques. |
| CFN95279 | N-trans-p-Coumaroyltyrosine |
| CFN95280 | Somnifericin |
| CFN95281 | Arganine B |
| CFN95282 | Grosvenorin 2''-glucoside |
| CFN95283 | (+)-Lariciresinol 4'-O-beta-D-Glucopyranosyl-(1->3)-beta-D-glucopyranoside |
| CFN91822 | 28-Homobrassinolide |
| CFN91821 | 24-Epibrassinolide |
| CFN91820 | Seselin |
| CFN91819 | N-Formylcytisine |
| CFN91818 | Lappaconine |
| CFN91817 | N-Methylcolchicine |
| CFN91816 | Candicine |
| CFN95284 | Isoengeletin |
| CFN95285 | 1-(3',5'-dimethoxy)phenyl-2-[4''-O-beta-D-glucopyranosyl (6->1)-O-alpha-L-rhamnopyranosyl]phenylethane 1-(3',5'-dimethoxy)phenyl-2-[4''-O-β-D-glucopyranosyl (6→1)-O-α-L-rhamnopyranosyl]phenylethane showed cytotoxic activities to Hela and hep2 cell lines. |
| CFN95286 | Lyciumamide B |
